Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)
CUSIP: G8807B106
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Ordinary Share $0.00001 Par Value
- Shares outstanding
- 51,428,000
- Total 13F shares
- 47,101,751
- Share change
- -955,206
- Total reported value
- $399,477,630
- Put/Call ratio
- 22%
- Price per share
- $8.48
- Number of holders
- 129
- Value change
- -$8,156,185
- Number of buys
- 63
- Number of sells
- 59
Quarterly Holders Quick Answers
What is CUSIP G8807B106?
CUSIP G8807B106 identifies TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G8807B106:
Top shareholders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Weiss Asset Management LP |
3/4/5
13F
|
10%+ Owner · Company |
14%
from 13F
|
7,457,060
|
$76,733,147 | — | 19 Sep 2022 | |
| Madison Avenue Partners, LP |
13F
|
Company |
14%
|
7,012,226
|
$62,899,667 | — | 31 Mar 2024 | |
| BAUPOST GROUP LLC/MA |
13F
|
Company |
13%
|
6,594,126
|
$59,149,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.2%
|
4,208,337
|
$37,748,782 | — | 31 Mar 2024 | |
| Irenic Capital Management LP |
13F
|
Company |
5.4%
|
2,760,948
|
$24,765,704 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.2%
|
2,685,853
|
$24,092,101 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
4%
|
2,043,611
|
$18,371,909 | — | 31 Mar 2024 | |
| Newtyn Management, LLC |
13F
|
Company |
3.2%
|
1,643,930
|
$14,746,052 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
1,368,781
|
$12,277,966 | — | 31 Mar 2024 | |
| Oasis Management Co Ltd. |
13F
|
Company |
2.3%
|
1,157,965
|
$10,386,946 | — | 31 Mar 2024 | |
| Park West Asset Management LLC |
13F
|
Company |
2.3%
|
1,157,163
|
$10,379,752 | — | 31 Mar 2024 | |
| Camber Capital Management LP |
13F
|
Company |
1.9%
|
1,000,000
|
$8,970,000 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
967,452
|
$8,678,893 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.5%
|
781,585
|
$7,010,817 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.1%
|
557,971
|
$5,005,000 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
520,496
|
$4,668,849 | — | 31 Mar 2024 | |
| Frank Pasqualone |
3/4/5
|
SVP, CHIEF BUSINESS OFFICER |
—
class O/S missing
|
429,783
|
$4,422,467 | — | 19 Nov 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.95%
|
488,752
|
$4,384,106 | — | 31 Mar 2024 | |
| Andrew A. Hindman |
3/4/5
|
SVP, CHIEF FINANCIAL OFFICER |
—
class O/S missing
|
384,714
|
$3,958,707 | — | 18 Nov 2022 | |
| Kenneth R. Pitzer |
3/4/5
|
SVP, PROD STRAT & COMM PLNG |
—
class O/S missing
|
380,123
|
$3,911,466 | — | 18 Feb 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.81%
|
419,113
|
$3,759,443 | — | 31 Mar 2024 | |
| Philip D. Worboys |
3/4/5
|
SVP, RESEARCH & TRANSL SCIENCE |
—
class O/S missing
|
330,752
|
$3,403,438 | — | 19 Nov 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.64%
|
330,962
|
$2,968,730 | — | 31 Mar 2024 | |
| Bradford J. Shafer |
3/4/5
|
EVP, Gen. Counsel, Secretary |
—
class O/S missing
|
277,831
|
$2,858,881 | — | 20 Aug 2021 | |
| Richard A. Graham |
3/4/5
|
SVP, RESEARCH & DEVELOPMENT |
—
class O/S missing
|
314,915
|
$2,809,042 | — | 20 Feb 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.6%
|
310,501
|
$2,785,194 | — | 31 Mar 2024 | |
| Vijay Sabesan |
3/4/5
|
SVP, TECHNICAL OPERATIONS |
—
class O/S missing
|
235,524
|
$2,423,542 | — | 19 Nov 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.46%
|
238,502
|
$2,139,363 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.43%
|
222,750
|
$1,998,068 | — | 31 Mar 2024 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.41%
|
209,566
|
$1,880,000 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.41%
|
208,783
|
$1,873,000 | — | 31 Mar 2024 | |
| Chescapmanager LLC |
13F
|
Company |
0.39%
|
201,365
|
$1,806,244 | — | 31 Mar 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.35%
|
177,612
|
$1,593,180 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.32%
|
162,073
|
$1,453,795 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.32%
|
162,028
|
$1,453,391 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.31%
|
159,818
|
$1,433,567 | — | 31 Mar 2024 | |
| Burton G. Malkiel |
3/4/5
|
Director |
—
mixed-class rows
|
137,633
mixed-class rows
|
$1,189,411 | — | 02 May 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.26%
|
131,389
|
$1,178,000 | — | 31 Mar 2024 | |
| Ann Brady |
3/4/5
|
PRESIDENT, TBIL |
—
class O/S missing
|
110,319
|
$1,135,183 | — | 18 Feb 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.24%
|
125,901
|
$1,129,332 | — | 31 Mar 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.23%
|
119,758
|
$1,074,229 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.23%
|
115,808
|
$1,038,798 | — | 31 Mar 2024 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.22%
|
115,418
|
$1,035,299 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.22%
|
111,772
|
$1,002,595 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.18%
|
92,179
|
$826,830 | — | 31 Mar 2024 | |
| William D. Young |
3/4/5
|
Director |
—
mixed-class rows
|
106,010
mixed-class rows
|
$802,723 | — | 26 Apr 2022 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.16%
|
80,755
|
$724,000 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.14%
|
73,742
|
$661,466 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.14%
|
72,635
|
$651,536 | — | 31 Mar 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.13%
|
66,436
|
$599,252 | — | 31 Mar 2024 |
Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) as of Q2 2024
As of 30 Jun 2024,
Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,101,751 shares.
The largest 10 holders included
Madison Avenue Partners, LP, Weiss Asset Management LP, BAUPOST GROUP LLC/MA, BlackRock Inc., Irenic Capital Management LP, Newtyn Management, LLC, VANGUARD GROUP INC, Park West Asset Management LLC, STATE STREET CORP, and Oasis Management Co Ltd..
This page lists
129
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
119
Q2 2024 holders
129
Holder diff
10
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.